TrialPanorama/TrialPanorama-database huggingface dataset:
Study 31642045 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31642446 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 31644329 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 31644841 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 31647026 — Pharmacodynamic Biomarker (PDY): Retinoblastoma-associated protein
Genes: RB1
Study 31647026 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 31647026 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 31647530 — Predictive Biomarker (PRD): SCN5A mRNA
Genes: SCN5A
Study 31647861 — Predictive Biomarker (PRD): BBC3 mRNA
Genes: BBC3; PUMA
Study 31648294 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 31648999 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 31648999 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 31650066 — Predictive Biomarker (PRD): MYB mRNA
Genes: MYB
Study 31650067 — Predictive Biomarker (PRD): HPSE mRNA
Genes: HPSE; HEP; HPA; HPA1; HPR1; HPSE1; HSE1
Study 31650161 — Predictive Biomarker (PRD): GLS2 mRNA
Genes: GLS2; GA
Study 31650176 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 31650393 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 31650393 — Surrogate Endpoint (SUR): Serum creatinine
Study 31651359 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 31651363 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study 31652009 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 31652997 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 31652997 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31652997 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 31653207 — Surrogate Endpoint (SUR): Blood pressure
Study 31654541 — Predictive Biomarker (PRD): LAT mRNA
Genes: LAT
Study 31655222 — Predictive Biomarker (PRD): ACVR1 mRNA
Genes: ACVR1; ACVRLK2
Study 31656217 — Pharmacodynamic Biomarker (PDY): Error related negativity
Study 31657082 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 31657082 — Predictive Biomarker (PRD): OCA2 mRNA
Genes: OCA2; D15S12; P
Study 31657648 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study 31659739 — Predictive Biomarker (PRD): PTS mRNA
Genes: PTS
Study 31659847 — Predictive Biomarker (PRD): CD46 mRNA
Genes: CD46; MCP; MIC10
Study 31659847 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 31659847 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31659847 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 31659915 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 31660903 — Surrogate Endpoint (SUR): Pathological complete response
Study 31662412 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 31662765 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Osteopontin
Genes: SPP1; BNSP; OPN; PSEC0156
Study 31662893 — Predictive Biomarker (PRD): AXL mRNA
Genes: AXL; UFO
Study 31663465 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31663465 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 31664962 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 31664962 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 31665141 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31665480 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 31665959 — Surrogate Endpoint (SUR): Blood pressure
Study 31666276 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Plasma DNA
Study 31667609 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 31668140 — Predictive Biomarker (PRD): KLHL17 mRNA
Genes: KLHL17; AF
Study 31668140 — Predictive Biomarker (PRD): TCFL5 mRNA
Genes: TCFL5; CHA; E2BP1
Study 31668571 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 31668633 — Predictive Biomarker (PRD): PLIN1 mRNA
Genes: PLIN1; PERI; PLIN
Study 31668825 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 31669155 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study 31669155 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 31670336 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study 31670483 — Predictive Biomarker (PRD): BCL2A1 mRNA
Genes: BCL2A1; BCL2L5; BFL1; GRS; HBPA1
Study 31672031 — Predictive Biomarker (PRD): HPR mRNA
Genes: HPR
Study 31672144 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31672144 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 31672148 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 31672148 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 31672853 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 31673295 — Predictive Biomarker (PRD): AGER mRNA
Genes: AGER; RAGE
Study 31673295 — Predictive Biomarker (PRD): GLO1 mRNA
Genes: GLO1
Study 31673295 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31673391 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 31673415 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31673422 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31673978 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 31675683 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 31675683 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 31675683 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 31675683 — Predictive Biomarker (PRD): Hormone receptor
Study 31675925 — Surrogate Endpoint (SUR): Blood pressure
Study 31675925 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31675952 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 31676359 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 31676359 — Predictive Biomarker (PRD): FUT3 mRNA
Genes: FUT3; FT3B; LE
Study 31676359 — Predictive Biomarker (PRD): FUT2 mRNA
Genes: FUT2; SEC2
Study 31676359 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study 31676359 — Predictive Biomarker (PRD): GAL3ST2 mRNA
Genes: GAL3ST2; GP3ST
Study 31676359 — Predictive Biomarker (PRD): FUT6 mRNA
Genes: FUT6; FCT3A
Study 31676359 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 31676359 — Predictive Biomarker (PRD): B3GNT3 mRNA
Genes: B3GNT3; B3GALT8; TMEM3; UNQ637/PRO1266
Study 31676359 — Predictive Biomarker (PRD): FAM3B mRNA
Genes: FAM3B; C21orf11; C21orf76; PRED44; UNQ320/PRO365
Study 31678032 — Pharmacodynamic Biomarker (PDY): Leucine-rich repeat kinase 2
Genes: LRRK2; PARK8
Study 31678032 — Pharmacodynamic Biomarker (PDY): Lysosomal acid glucosylceramidase
Genes: GBA1; GBA; GC; GLUC
Study 31678032 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study 31678771 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 31679176 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 31682550 — Predictive Biomarker (PRD): Microsatellite instability
Study 31682968 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study 31685491 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 31687205 — Surrogate Endpoint (SUR): Blood pressure
Study 31688003 — Surrogate Endpoint (SUR): Blood pressure
Study 31688330 — Predictive Biomarker (PRD): IK mRNA
Genes: IK; RED; RER
Study 31689155 — Predictive Biomarker (PRD): STEAP1 mRNA
Genes: STEAP1; PRSS24; STEAP
Study 31689874 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study 31689874 — Predictive Biomarker (PRD): FSCN1 mRNA
Genes: FSCN1; FAN1; HSN; SNL
Study 31690284 — Surrogate Endpoint (SUR): Blood pressure
Study 31690286 — Predictive Biomarker (PRD): FMOD mRNA
Genes: FMOD; FM; SLRR2E
Study 31690697 — Predictive Biomarker (PRD): FGFR3 mRNA
Genes: FGFR3; JTK4
Study 31690697 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study 31690932 — Predictive Biomarker (PRD): FSTL3 mRNA
Genes: FSTL3; FLRG; UNQ674/PRO1308
Study 31690932 — Predictive Biomarker (PRD): IGFBP3 mRNA
Genes: IGFBP3; IBP3
Study 31691133 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31691892 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 31691892 — Monitoring Biomarker (MOI): Cell-free DNA
Study 31691892 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Plasma DNA
Study 31693535 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 31693535 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 31694553 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31695074 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 31695346 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31695347 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 31695347 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31695347 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 31697246 — Surrogate Endpoint (SUR): Blood pressure
Study 31697308 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31697647 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31698104 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31698328 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 31698328 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study 31700871 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 31701169 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 31703604 — Predictive Biomarker (PRD): LAG3 mRNA
Genes: LAG3; FDC
Study 31703604 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 31703728 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 31704699 — Predictive Biomarker (PRD): ACD mRNA
Genes: ACD; PIP1; PTOP; TINT1; TPP1
Study 31705855 — Surrogate Endpoint (SUR): Blood pressure
Study 31707975 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study 31708296 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 31708824 — Safety Biomarker (SAF): BDNF
Study 31709648 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study 31710193 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study 31710528 — Surrogate Endpoint (SUR): Blood pressure
Study 31710684 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 31710793 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 31710864 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study 31710864 — Predictive Biomarker (PRD): CCDC6 mRNA
Genes: CCDC6; D10S170; TST1
Study 31712445 — Predictive Biomarker (PRD): SFRP1 mRNA
Genes: SFRP1; FRP; FRP1; SARP2
Study 31712445 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PENK mRNA
Genes: PENK
Study 31712445 — Predictive Biomarker (PRD): NPY mRNA
Genes: NPY
Study 31712445 — Predictive Biomarker (PRD): ALX4 mRNA
Genes: ALX4; KIAA1788
Study 31712445 — Predictive Biomarker (PRD): WIF1 mRNA
Genes: WIF1; UNQ191/PRO217
Study 31713013 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 31714428 — Predictive Biomarker (PRD): UCP1 mRNA
Genes: UCP1; SLC25A7; UCP
Study 31714428 — Predictive Biomarker (PRD): PRDM16 mRNA
Genes: PRDM16; KIAA1675; MEL1; PFM13
Study 31714428 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31714428 — Predictive Biomarker (PRD): TMEM26 mRNA
Genes: TMEM26
Study 31714428 — Predictive Biomarker (PRD): TNFRSF9 mRNA
Genes: TNFRSF9; CD137; ILA
Study 31714428 — Predictive Biomarker (PRD): ZIC1 mRNA
Genes: ZIC1; ZIC; ZNF201
Study 31714428 — Predictive Biomarker (PRD): P2RX5 mRNA
Genes: P2RX5; P2X5
Study 31718534 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 31718534 — Predictive Biomarker (PRD): CD27 mRNA
Genes: CD27; TNFRSF7
Study 31718534 — Predictive Biomarker (PRD): CD5 mRNA
Genes: CD5; LEU1
Study 31718666 — Predictive Biomarker (PRD): CHN1 mRNA
Genes: CHN1; ARHGAP2; CHN
Study 31718666 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 31718676 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 31719258 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 31719684 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 31719684 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 31720254 — Surrogate Endpoint (SUR): Blood pressure
Study 31720254 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31721017 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 31721017 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 31721213 — Safety Biomarker (SAF): Reactive oxygen species
Study 31721246 — Predictive Biomarker (PRD): SRL mRNA
Genes: SRL
Study 31721246 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study 31721643 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 31722205 — Predictive Biomarker (PRD): IFNAR1 mRNA
Genes: IFNAR1; IFNAR
Study 31722680 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 31722680 — Surrogate Endpoint (SUR): Blood pressure
Study 31722680 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31723837 — Predictive Biomarker (PRD): Liver iron
Study 31725351 — Predictive Biomarker (PRD): Microsatellite instability
Study 31725351 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 31725351 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 31725459 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 31725459 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Matrix metalloproteinase 3
Genes: MMP3; STMY1
Study 31725531 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 31725531 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31725531 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31726319 — Surrogate Endpoint (SUR): Blood pressure
Study 31726422 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31726452 — Predictive Biomarker (PRD): GAST mRNA
Genes: GAST; GAS
Study 31727019 — Predictive Biomarker (PRD): TRAPPC9 mRNA
Genes: TRAPPC9; KIAA1882; NIBP; T1
Study 31727075 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 31727113 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 31727136 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31728032 — Predictive Biomarker (PRD): AIP mRNA
Genes: AIP; XAP2
Study 31728032 — Surrogate Endpoint (SUR): Serum uric acid
Study 31731085 — Surrogate Endpoint (SUR): Blood pressure
Study 31731085 — Surrogate Endpoint (SUR): Forced vital capacity
Study 31732519 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 31732566 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC18A2 mRNA
Genes: SLC18A2; SVMT; VMAT2
Study 31732715 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study 31734214 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 31734525 — Predictive Biomarker (PRD): NPSR1 mRNA
Genes: NPSR1; GPR154; GPRA; PGR14
Study 31734820 — Surrogate Endpoint (SUR): Serum uric acid
Study 31734832 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study 31734832 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 31734832 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Growth/differentiation factor 15
Genes: GDF15; MIC1; PDF; PLAB; PTGFB
Study 31734899 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31735660 — Surrogate Endpoint (SUR): Blood pressure
Study 31735691 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 31738181 — Surrogate Endpoint (SUR): Serum creatinine
Study 31738425 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study 31738425 — Predictive Biomarker (PRD): ETV6 mRNA
Genes: ETV6; TEL; TEL1
Study 31738425 — Predictive Biomarker (PRD): NTRK3 mRNA
Genes: NTRK3; TRKC
Study 31743993 — Safety Biomarker (SAF): Transforming growth factor beta 1
Genes: TGFB1; TGFB
Study 31744895 — Predictive Biomarker (PRD): MAPK3 mRNA
Genes: MAPK3; ERK1; PRKM3
Study 31745699 — Predictive Biomarker (PRD): CYBB mRNA
Genes: CYBB; NOX2
Study 31745699 — Predictive Biomarker (PRD): NCF2 mRNA
Genes: NCF2; NOXA2; P67PHOX
Study 31745703 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 31745703 — Predictive Biomarker (PRD): FOXP1 mRNA
Genes: FOXP1; HSPC215
Study 31745703 — Predictive Biomarker (PRD): WWOX mRNA
Genes: WWOX; FOR; SDR41C1; WOX1
Study 31745902 — Surrogate Endpoint (SUR): Serum creatinine
Study 31748196 — Predictive Biomarker (PRD): CCS mRNA
Genes: CCS
Study 31748220 — Predictive Biomarker (PRD): DCLRE1C mRNA
Genes: DCLRE1C; ARTEMIS; ASCID; SCIDA; SNM1C
Study 31749608 — Predictive Biomarker (PRD): FOS mRNA
Genes: FOS; G0S7
Study 31749981 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 31753019 — Predictive Biomarker (PRD): BTLA mRNA
Genes: BTLA
Study 31753019 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 31753788 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 31753788 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 31753878 — Surrogate Endpoint (SUR): Blood pressure
Study 31755936 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31756405 — Predictive Biomarker (PRD): MVP mRNA
Genes: MVP; LRP
Study 31758517 — Predictive Biomarker (PRD): PTGS1 mRNA
Genes: PTGS1; COX1
Study 31758773 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 31758773 — Surrogate Endpoint (SUR): Blood pressure
Study 31759037 — Predictive Biomarker (PRD): LAMB2 mRNA
Genes: LAMB2; LAMS
Study 31760711 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 31760881 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 31760881 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 31761940 — Surrogate Endpoint (SUR): Bone mineral density
Study 31763491 — Predictive Biomarker (PRD): OSR1 mRNA
Genes: OSR1; ODD
Study 31765809 — Surrogate Endpoint (SUR): Blood pressure
Study 31766870 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 31767197 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study 31767578 — Surrogate Endpoint (SUR): Bone mineral density
Study 31768187 — Predictive Biomarker (PRD): PLG mRNA
Genes: PLG
Study 31768187 — Predictive Biomarker (PRD): F12 mRNA
Genes: F12
Study 31768261 — Surrogate Endpoint (SUR): Blood pressure
Study 31768930 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 31769793 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31770616 — Predictive Biomarker (PRD): CDKN2B-AS1
Study 31770616 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31770616 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31770616 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 31771603 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31771603 — Surrogate Endpoint (SUR): Blood pressure
Study 31771607 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31771630 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31772121 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 31772121 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 31772121 — Predictive Biomarker (PRD): Hormone receptor
Study 31773324 — Surrogate Endpoint (SUR): Blood pressure
Study 31773439 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 31773439 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 31774125 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 31774125 — Predictive Biomarker (PRD): SLC25A18 mRNA
Genes: SLC25A18; GC2
Study 31774125 — Surrogate Endpoint (SUR): Blood pressure
Study 31774522 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 31774688 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1